MRK to 132MRK (Merck & Co., Inc.) has been consistently rising in a channel since 2022, even during the 2022 bear market. Consider entering near the channel’s bottom for a potential profit target around 118.39. A breakout could push it to 132 by year-end.Longby TriumphOne2
#MRK Straddle Detected! Notional Value- 1.6M$.Based on our team's research of the options market, we expect buy activity at the support level or sell activity at the resistance. We do research and find new opportunities every day! Please feel free to leave any comments you have and like this idea if you agree with us. Any feedback or comments will be read. We appreciate it all!by ClashChartsTeam7
$MRK with a bullish outlook following its earnings #StocksThe PEAD projected a bullish outlook for NYSE:MRK after a positive under reaction following its earnings release placing the stock in drift A with an expected accuracy of 77.78%.Longby EPSMomentum0
Merck: Water slide 🛝The pool-season is about to start, and Merck has already secured its place on the water slide, which should take it further downwards below the support at $110.66. However, there is still a 35% chance that the share might catch a bubbling fountain which could push it above the resistance at $119.65. In that case, we would expect Merck to develop a new top in the form of wave alt.B in green in the green zone between $119.87 and $123.79 first before turning downwards again.by MarketIntel0
MRK - Rising Trend Channel [MID TERM]- MRK is in a rising trend channel in the medium long term. - The price has risen strongly since the positive signal from the rectangle formation at the break through resistance at 95.58. - The stock has broken up through resistance at 115. - Volume tops and volume bottoms correspond badly with tops and bottoms in the price. - The short term momentum of the stock is strongly positive, with RSI above 70. - This indicates increasing optimism among investors and further price increase for MRK. However, particularly for big stocks, high RSI may be a sign that the stock is overbought and that there is a chance of a reaction downwards. - Overall assessed as technically positive for the medium long term. *EP: Enter Price, SL: Support, TP: Take Profit, CL: Cut Loss, TF: Time Frame, RST: Resistance, RTS: Resistance to be Support LT TP: Long Term Target Price *Chart Pattern: DT - Double Top | BEARISH | RED DB - Double Bottom | BULLISH | GREEN HNS - Head & Shoulder | BEARISH | RED REC - Rectangle | BLUE iHNS - inverse head & Shoulder | BULLISH | GREEN Verify it first and believe later. WavePoint ❤️Longby wavepoint990
$MRK UndervaluedHigh Quality and Undervalued NYSE:MRK These eight indicators are all Bullish. If you owned NYSE:MRK for the last 5 years, then you have doubled your investment. There is no guarantee of the future but it looks like the near future target price is $121 Earnings Date: 27th April 2023 On-balance volume (OBV): Bullish Accumulation/distribution line: Bullish Average directional index (ADX): Bullish Aroon oscillator: Bullish Moving average convergence divergence (MACD): Bullish Relative strength index (RSI): Bullish Stochastic oscillator: Bullish Trend based on moving average crossover strategy: Bullishby VIN7860
Merck Could Be Breaking OutMerck surged in late 2022 and consolidated during the first quarter. Now the drug maker could be breaking out. The first pattern on today’s chart is the rally between mid-October and early January, which included a breakout to new record highs. MRK then pulled back and retraced almost exactly half the move by early February. It bounced a little before making a slightly higher monthly low in late March. Second, MACD was rising in October before the previous surge. Notice how it’s climbing in a similar way now. Next is the 100-day simple moving average (SMA). The stock rallied from it in October -- also resembling the current price action. Finally, in the shorter term you have the March 7 high of $112.18. Consider how MRK briefly paused at that level in the last two weeks before proceeding to new record territory on Thursday. TradeStation has, for decades, advanced the trading industry, providing access to stocks, options, futures and cryptocurrencies. See our Overview for more. Important Information TradeStation Securities, Inc., TradeStation Crypto, Inc., and TradeStation Technologies, Inc. are each wholly owned subsidiaries of TradeStation Group, Inc., all operating, and providing products and services, under the TradeStation brand and trademark. TradeStation Crypto, Inc. offers to self-directed investors and traders cryptocurrency brokerage services. It is neither licensed with the SEC or the CFTC nor is it a Member of NFA. When applying for, or purchasing, accounts, subscriptions, products, and services, it is important that you know which company you will be dealing with. Please click here for further important information explaining what this means. This content is for informational and educational purposes only. This is not a recommendation regarding any investment or investment strategy. Any opinions expressed herein are those of the author and do not represent the views or opinions of TradeStation or any of its affiliates. Investing involves risks. Past performance, whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. There is a possibility that you may sustain a loss equal to or greater than your entire investment regardless of which asset class you trade (equities, options, futures, or digital assets); therefore, you should not invest or risk money that you cannot afford to lose. Before trading any asset class, first read the relevant risk disclosure statements on the Important Documents page, found here: www.tradestation.com .by TradeStation12
long position on MRKMy strtegy is based on price action with the reading of certain indicators that I like whilerespecting all the values that define the stock maketLongby batchangoyves2020
MRK ShortToday MRK broke 50 SMA while can not hold resistance at 109. I think the downtrend for this underlying will continue. as it happens the price of MRK could test the 103s levelShortby orkhanrustamov0
long position on MRKMy strategy is based on price action with the reading of certain indicators that I like while respecting all the values that define the stock maket Longby batchangoyves2021
long position on MRKMy strategy is based on price action with the reading of certain indicators that I like while respecting all the values that define the stock maket Longby batchangoyves2020
MERCK Stock Chart Fibonacci Analysis 030623 1) Find a FIBO Slingshot 2) Check FIBO 61.80% level 3) Entry Point > 109/61.80%by fibonacci61802
$MRK with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $MRK after a Negative Under reaction following its earnings release placing the stock in drift D with an expected accuracy of 77.78%. Longby EPSMomentum0
(MRK) - Price Targets & Stop Loss 📈 What’s up investors! 📉 Welcome back to another one of 💡“Mike’s Ideas”.💡 I post as I find signals… these signals are based on the personal rules I have built and follow in order to make up what I call the “SST Strategy”. Follow for more ideas in the future!! I have 4 levels marked and colour coded on the Chart. These levels are: 🔴 Red = Stop Loss 🟢 Green = 1.2:1 Risk Reward Ratio 🟡 Yellow = 1.5:1 Risk Reward Ratio 🔵 Blue = 2:1 Risk Reward Ratio 👀 So what are we looking at today…!!! 🚨(MRK) Merck & Co., Inc.🚨 Operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.Longby sststrategyUpdated 4
MRK Divergences + Trendline breakMRK broke below its trendline with both a MACD and RSI Divergence. Volume profile doesn't look supportive at these prices. Healthcare names have been a safe hiding place through the recent sell offShortby SoVeryLostUpdated 3
MRK Bearish EngulfingNasty bearish engulfing candle larger than the previous 2 days. Had completed a 9count on 11/30, chopping around since, losing 108.6 volume shelf sends it downShortby SoVeryLostUpdated 0
MRK | Time for Puts | MerckMerck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.Shortby DivergenceSeeker113
TOP US-Stocks: Buy-Signal MRKThe stock just broke through a perfect buy point and triggered a buy-signal. The stop loss level and profit target are shown in the graphic. All stocks on our watchlists meet the hard selection criteria according to Mark Minervini's Trend-Template and William o' Neil's CAN SLIM methodology AND are in the process of developing a Perfect Buy Point and a low-risk entry, following a volatility contraction pattern. The stock just broke through a perfect buy point and triggered a buy-signal. The stop loss level and profit target are shown in the graphic. 🍾🍾 We trade like the Champions 🍾🍾 Are you struggling with your trading strategy? Follow me to get free, real-time trading signals which are all based on Mark Minervini's success-proven strategy. Longby JS_TechTrading2
RectanglePrice is above the Rectangle. Target 1 has been met. No recommendation/price is at ATHby lauralea0
$MRK with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $MRK after a Positive Under reaction following its earnings release placing the stock in drift A with an expected accuracy of 75%. Longby EPSMomentum1